Omar Mian, MD, PhD, Cleveland Clinic, Cleveland, OH, discusses the role of cancer epigenetics to classify tumour behaviour and enable patient-tailored treatment decisions. This interview took place at the American Society for Radiation Oncology (ASTRO) 2022 Congress in San Antonio, Tx.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.